Charles Cleeland

The following biographical sketch is from Appendix E of the Institute of Medicine report, ''Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.

"'Charles S. Cleeland, Ph.D., is a McCullough professor of cancer research and chair, Department of Symptom Research, at the University of Texas MD Anderson Cancer Center. He is a leader in the area of cancer symptom epidemiology, assessment, and treatment. He has directed epidemiological studies of pain and other symptoms in patients with cancer; studies of the mechanisms of pain and other symptoms; studies using positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) to examine the effects of pain on cortical activity; and clinical trials aimed at reducing the risk of inadequate symptom control, including in underserved populations. Dr. Cleeland is a member and past president of the board of directors of the U.S. Cancer Pain Relief Committee. He is also past president of the American Pain Society. His research is widely published. He has published numerous studies on the prevalence and severity of cancer symptoms, on U.S. and international symptom management practice patterns, and on potential biological mechanisms underlying the symptoms produced by cancer and its treatment.'"

Education

 * NIH Postdoctoral Fellow - Neurology, University of Wisconsin, Madison, WI
 * PHD - Washington University, St. Louis, MO, Clinical Psychology
 * BA - Wesleyan University, Middletown, CT, with honors, Psychology

Awards

 * 2010 	Raymond Houde Award and Lecture, Eastern Pain Society
 * 2009 	Award for Excellence in Contributions to the Committee for Rehabilitation and Palliative Care, The Chinese Anti-Cancer Association
 * 2008 	30th Annual Dr. John J. Bonica Award, Eastern Pain Association
 * 2007 	Trish Greene Quality of Life Award, American Cancer Society
 * 2002 	Fordyce Clinical Investigator Award, American Pain Society
 * 2000 	Distinguished Service Award, American Pain Society